CFDE Data Portal | Search VAV2

	Label	Description
	VAV2 Gene (Entity type)	ENSG00000160293 - vav guanine nucleotide exchange factor 2
	VAV2 associations Collection (Entity type)	Associations for VAV2_associations
	VAV2 associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	VAV2 HUMAN Protein (Entity type)	Guanine nucleotide exchange factor VAV2
	VAV2 MOUSE Protein (Entity type)	Guanine nucleotide exchange factor VAV2
	GSE114883 romidepsin T cell 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE172016 2 V 5 PACLITAXEL HUMAN UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE102757 1 V 0 PANOBINOSTAT MOUSE UP Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 6 v 11 human up Gene Set (Entity type)	A Gene Set from LINCS

VAV2

ENSG00000160293 - vav guanine nucleotide exchange factor 2

VAV2 associations

Associations for VAV2_associations

VAV2 associations.tsv

A file from IDG as part of the Harmonizome project

VAV2 HUMAN

Guanine nucleotide exchange factor VAV2

VAV2 MOUSE

Guanine nucleotide exchange factor VAV2

GSE114883 romidepsin T cell 1 v 2 human up

A Gene Set from LINCS

GSE265788 IDH1 inhibition RNA-Directed DNA Polymerase 3 v 2 human dn

A Gene Set from LINCS

GSE172016 2 V 5 PACLITAXEL HUMAN UP

A Gene Set from LINCS

GSE102757 1 V 0 PANOBINOSTAT MOUSE UP

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 6 v 11 human up

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.